Notably, AIM2 expression was notably elevated in RCC tumor tissues compared to normal tissues, leading to the promotion of RCC development through the phosphorylation and proteasomal degradation of FOXO3a. This evidence concerns the gene FOXO3 and renal cell carcinoma.